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Perhaps you will be surprised to find a paper on a canine disease in a journal of human 
genetics. As indeed, in this edition on page xxx you will find an article by van Poucke 
et al. about four Malinois dogs, who presented with neurological abnormalities, 
including ataxia, myokymia (involuntary, spontaneous, localized quivering of muscles) 
and generalized seizures.1 Further investigations of brainstem auditory evoked 
potentials revealed also abnormalities in hearing. Genetic investigations subsequently 
identified a homozygous variant in kcnj10 as the cause of the problem. So, can we 
learn something from these observations in "man's best friend"?  Indeed, medical care 
for animals, at least in some parts of Western society, has reached similar 
sophistication as for humans, including professional subspecialization2. And this 
includes genetics: OMIA (www.omia.org), the veterinary equivalent of OMIM 
(www.omim.org), lists at present 202 gene records relevant for dogs. 
So, what can we learn from Snoopy and his friends? 
Recessive mutations in KCNJ10 are the cause of EAST syndrome (also described as 
SeSAME syndrome) a rare disorder characterized by Epilepsy, Ataxia, Sensorineural 
deafness and Tubulopathy3. To date less than 30 patients with 14 different mutations 
have been reported4-6. It is the neurological aspects that are typically most debilitating 
in this disorder with severely affected patients being almost completely restricted in 
their ability to communicate either verbally or in written form due to their speech 
apraxia and ataxia. In addition, they suffer from recurrent seizures7. There is no 
specific treatment for EAST syndrome and animal models are needed to identify and 
test potential drugs8. It is in this context that the finding of a canine equivalent of EAST 
syndrome is of interest. And perhaps, this also illustrates the artificial gulf between 
human and veterinary medicine. These authors have a strong personal interest in 
EAST syndrome, but were not aware of a previously described canine model, as it had 
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been published in a veterinary journal9. It is only the submission to this journal of 
human genetics that alerted us to its existence. Yet collaboration between these 
disciplines is highly desirable as insights from one species can inform the treatment 
and understanding of the disease in others. For instance, one of the dogs reported in 
this edition had a postmortem examination, showing a myelopathy in the central 
nervous system affecting the cerebellum, brainstem and spinal cord. Interestingly, 
changes were not obvious on macroscopic examination, but only on histology. This 
reflects our experience with MRI imaging of human patients, which were initially 
reported as normal3, and only after careful examination of imaging from multiple 
patient were subtle changes in the cerebellum and spinal tract noted7. This also 
parallels the experience of the previous report of kcnj10 mutations in Jack Russel 
Terriers, as MRI images were reported as normal, yet histopathological investigations 
revealed spinocerebellar myelopathy9.  
However, there are also limitations to the comparability of manifestations of kcnj10 
disease between dog and men. A cardinal feature of the human disease is a specific 
salt-wasting tubulopathy10. Curiously, this has not been demonstrated in dogs, 
although it was not examined in the Jack Russell Terriers and blood tests were 
obtained in only two of the Malinois dogs, yet without concomitant urine studies. 
Nevertheless, the blood tests showed a normal electrolyte profile, suggesting that 
kcnj10 potentially has less relevance in renal tubular function in dog than in man. 
Yet, given that it is the neurological abnormalities that are most debilitating, these dogs 
could still prove a valuable model for the testing of any compounds identified for 
instance in Zebrafish screening, prior to testing in man. 
Moreover, the apparent absence of electrolyte abnormalities is also helpful 
information. To this day, patients with EAST syndrome often receive large dose of 
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potassium and magnesium supplementation in an attempt to normalize plasma levels, 
as the abnormal electrolytes are erroneously thought to contribute to or even cause 
the neurological complications. In patients with renal electrolyte wasting it is 
exceedingly difficult to normalize plasma levels, as the briefly increased levels in the 
glomerular filtrate lead to increased losses in the urine. Physicians sometimes respond 
with ever increasing doses of supplementation, which can cause complications such 
as diarrhea (worsening the electrolyte profile) and gastric irritation. In this context, the 
experience in dogs, that neurological manifestations occur in the apparent absence of 
electrolyte abnormalities further confirm that seizures and ataxia are due to the 
myelopathy and not from electrolyte imbalance and that attempts at normalizing 
plasma levels are thus not necessarily helpful. 
 
Besides providing a much needed diagnosis to the dogs’ owners, we thus welcome 
further detailed observations from our veterinary colleagues to inform the 
understanding and management of EAST syndrome. 
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